Immunoprotective activity of Listeria monocytogenes L-form cytoplasmic membranes in hamsters with transplanted myeloid tumors

Experimental Oncology

Volumn 21, Issue 1, 1999, Pages 24-29

  Ivanova, E ^a   Toshkova, R ^b  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Immunomodulators; Lymphocytes; Macrophages; Stable L forms; Transplanted tumors

Indexed keywords

EID: 0013641455     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cohen M, Panos C. Membrane lipid composition of Streptococcus pyogenes and derived L-form. Biochem 1966; 5: 2385-97.
2. Fildler IJ, Schroit A. Synergism between lymphokines and muramyldipeptide encapsulated in liposomes: in situ activation of spontaneous cancer metastasis. J Immunol 1984, 133: 515.
3. Gumpert J, Schade W, Krebs B, Baykousheva S, Ivanova E, Toshkov A. Specificity in the phospholipid and fatty acid composition of the stable protoplast type L-form of E. coli B. Acta Microbiol Bulg 1984; 15: 17-23.
4. Ivanova E, Keranova B. Stimulating effect of Streptococcal L-forms and their cytoplasmic membranes on the cellular immune response in mice. CR Acad Bulg Sci 1992; 45 (4): 69-72.
5. Ivanova E, Kenarova B, Gumpert J. Adjuvant activity of the E. coli WF+ stable L-form cytoplasmic membranes. Acta Microbiol Bulg 1993; 29: 54-60.
6. Ivanova E, Naydensky H, Toshkova R, Gumpert J. Effect of E. coli WF+ L-form cytoplasmic membranes on the immune status of Yersinia pseudotuberculosis infected mice. Probl Inf Parasit Dis 1997; 24: 12-5.
7. Ivanova E, Svinarov D, Dimova M, Siromashkova M, Toshkov A. The lipid component of the lipopolisaccharide of L-form of Listeria monocytogenes. CR Acad Bulg Sci 1986, 39 (7): 139-41.
8. Ivanova E, Toshkova R, Gumpert J, Penev M. Effect of E. coli L-form cytoplasmic membrane experimentally induced diseases. CR Acad Bulg Sci 1991; 44 (2): 51-4.
9. Ivanova E, Toshkova R, Sotirov N, Gumpert J. Effect of cytoplasmic membranes of some parameters of immune status of hamsters experimentally infected by tumor of Graffi. CR Acad Bulg Sci 1991; 44 (3): 81-4.
10. Jakimov M, Mladenov Z, Konstantinov A, Janchev I. Transplantable myeloid tumor in hamster (MTH) induced by Graffi virus. Gen Comp Pathol 1979; 6: 24-35 (in Bulg.).
11. Lederer E. New developments in the field of synthetic muramilpeptides, especially as adjuvant for synthetic vaccines. Drug Exp Clin Res 1986, 12: 429-40.
12. Leu WR, Eddeston WF, Hadden JW, Good RA. Mechanism of action of migration inhibitory factor (MIF). Evidence for a receptor for MIF present on the peritoneal macrophages but not on alveolar macrophage. J Exp Med 1972; 136: 589-603.
13. Mason PR, Guanzura L. Reduced lymphocyte responses to mitogens in natural and experimental trichomoniasis. Infect Immunol 1990, 58: 3553-7.
14. Matsuzaki T, Shimizu Y, Yokokura T. Augmentation of antistatic effect on Lewis lung carcinoma in C57 BI16 mice by priming with Lactobacilus casei. Med Microbiol Immune 1990; 179: 161-8.
15. Mattman LH. Cell wall deficient forms: stealth pathogens. Florida: CRC Press Inc. 1993: 37-43.
16. Mihailova L, Siromashkova M, Ivanova E, Manev H, Toshkov A, Schmitt-Slomska J. Localization of the lipopolysaccharide in Listeria monocytogenes 4B and its stable L-form. Epidemiol Microbiol Infect Dis 1986, 23 (3): 27-32 (in Bulg.).
17. Michailova L, Ivanova E, Toshkov A. Ultrastucture features of the stable L-forms of some bacterial species. Acta Microbiol Bulg 1985; 17: 32-7 (in Bulg.).
18. Morizaki T, Torisu M. Enhanced adherence activity of OK 432-induced peritoneal neutrophils to tumor cells correlates to their increased expression of CD11b/CD18. Clin Immunol Immunophatol 1991; 59: 474-86.
19. Nesbitt JA, Lennarz WU. Comparison of lipids and lipolysaccharides from the bacillary and L-form of Proteus P18. J Bacteriol 1965; 89: 1010-25.
20. Osada Y, Mitsuyama M, Une T, Matsumoto K, Otani T, Ogava H, Nomoto K. Effect of L18 MDP (Ala), a synthetic derivate of muramyldipeptide on nonspecific resistance of mice of microbial infections. Infect Immunol 1982; 37: 292-300.
21. Serkejieva J, Ivanova E. Combined protective effect of an immunostimulatory bacterial preparation and rimantidine in experimental virus infection. Acta Virol 1997; 41: 65-70.
22. Siromashkova M, Sotirov N, Ivanova E, Andreeva S. Haemolysin in L-forms of Listeria monocytogenes. Epidem Microbiol Infect Dis 1989; 24 (3): 33-7 (in Bulg.).
23. Ushida A. Augmentation of autologous tumor killing activity of tumor associated granular lymphocytes by Streptococcal preparation OK 432. Exp Clin Pharmacol 1986; 8: 81-4.
24. Ushida A, Hoshino T. Reduction of supressor cells in cancer patients with OK 432 immunotherapy. Int J Cancer 1980; 26: 401-4.
25. Ward J., Perkins H. The chemical composition of the membranes of protoplasts and L-forms of Staphylococcus aureus. Biochem J 1968; 106: 391-400.
26. Wilson GS, Miles AA. Topley and Wilson's principles of bacteriology and immunity. 5th Ed, Vol 1. Edward Arnold (Publishers) Ltd, 1964: 528-35.